Literature DB >> 33481127

Intensifying Neoadjuvant Therapy for Rectal Cancers Towards Watchful Waiting.

Deep Chakrabarti1, Naseem Akhtar2, Shiv Rajan3, Sumaira Qayoom4, Vijay Kumar3, Arun Chaturvedi3, Rajeev Gupta1, Madan Lal Brahma Bhatt1.   

Abstract

Entities:  

Year:  2021        PMID： 33481127     DOI： 10.1245/s10434-020-09512-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  8 in total

Review 1.  Total neoadjuvant therapy for rectal cancer.

Authors:  K A Goodman
Journal:  Cancer Radiother       Date:  2018-05-26       Impact factor: 1.018

2.  Total neoadjuvant therapy for locally advanced rectal cancer: the fuse is lit.

Authors:  B R J Healey Bird
Journal:  Br J Surg       Date:  2020-10-26       Impact factor: 6.939

3.  Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study.

Authors:  B Ciseł; L Pietrzak; W Michalski; L Wyrwicz; A Rutkowski; E Kosakowska; A Cencelewicz; M Spałek; W Polkowski; M Jankiewicz; R Styliński; M Bębenek; B Kapturkiewicz; A Maciejczyk; J Sadowski; J Zygulska; W Zegarski; M Jankowski; M Las-Jankowska; Z Toczko; U Żelazowska-Omiotek; L Kępka; J Socha; E Wasilewska-Tesluk; W Markiewicz; J Kładny; A Majewski; W Kapuściński; R Suwiński; K Bujko
Journal:  Ann Oncol       Date:  2019-08-01       Impact factor: 32.976

4.  Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial.

Authors:  Y Francois; C J Nemoz; J Baulieux; J Vignal; J P Grandjean; C Partensky; J C Souquet; P Adeleine; J P Gerard
Journal:  J Clin Oncol       Date:  1999-08       Impact factor: 44.544

5.  Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.

Authors:  Renu R Bahadoer; Esmée A Dijkstra; Boudewijn van Etten; Corrie A M Marijnen; Hein Putter; Elma Meershoek-Klein Kranenbarg; Annet G H Roodvoets; Iris D Nagtegaal; Regina G H Beets-Tan; Lennart K Blomqvist; Tone Fokstuen; Albert J Ten Tije; Jaume Capdevila; Mathijs P Hendriks; Ibrahim Edhemovic; Andrés Cervantes; Per J Nilsson; Bengt Glimelius; Cornelis J H van de Velde; Geke A P Hospers
Journal:  Lancet Oncol       Date:  2020-12-07       Impact factor: 41.316

6.  Tumour regression after radiotherapy for rectal cancer - Results from the randomised Stockholm III trial.

Authors:  Johan Erlandsson; Ester Lörinc; Madelene Ahlberg; David Pettersson; Torbjörn Holm; Bengt Glimelius; Anna Martling
Journal:  Radiother Oncol       Date:  2019-04-01       Impact factor: 6.280

7.  Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study.

Authors:  K Bujko; L Wyrwicz; A Rutkowski; M Malinowska; L Pietrzak; J Kryński; W Michalski; J Olędzki; J Kuśnierz; L Zając; M Bednarczyk; M Szczepkowski; W Tarnowski; E Kosakowska; J Zwoliński; M Winiarek; K Wiśniowska; M Partycki; K Bęczkowska; W Polkowski; R Styliński; R Wierzbicki; P Bury; M Jankiewicz; K Paprota; M Lewicka; B Ciseł; M Skórzewska; J Mielko; M Bębenek; A Maciejczyk; B Kapturkiewicz; A Dybko; Ł Hajac; A Wojnar; T Leśniak; J Zygulska; D Jantner; E Chudyba; W Zegarski; M Las-Jankowska; M Jankowski; L Kołodziejski; A Radkowski; U Żelazowska-Omiotek; B Czeremszyńska; L Kępka; J Kolb-Sielecki; Z Toczko; Z Fedorowicz; A Dziki; A Danek; G Nawrocki; R Sopyło; W Markiewicz; P Kędzierawski; J Wydmański
Journal:  Ann Oncol       Date:  2016-02-15       Impact factor: 32.976

8.  Avoiding Unnecessary Major Rectal Cancer Surgery by Implementing Structural Restaging and a Watch-and-Wait Strategy After Neoadjuvant Radiochemotherapy.

Authors:  J F Huisman; I J H Schoenaker; R M Brohet; O Reerink; H van der Sluis; F C P Moll; E de Boer; J C de Graaf; W H de Vos Tot Nederveen Cappel; G L Beets; H L van Westreenen
Journal:  Ann Surg Oncol       Date:  2020-11-10       Impact factor: 5.344
  8 in total
  1 in total

1.  Identifying the long-term survival beneficiary of preoperative radiotherapy for rectal cancer in the TME era.

Authors:  Lei Wang; Xiaohong Zhong; Huaqin Lin; Xueqing Zhang; Lingdong Shao; Gang Chen; Junxin Wu
Journal:  Sci Rep       Date:  2022-03-17       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.